Atrium Ob/Gyn

New Portal Enhancements!

Hello!

The office will be closed on Wednesday, March 25th.

Our doors will reopen on Thursday, March 26th @ 7:30a with the scheduling lines opening at 8a.

If you think you are in labor, please call the office at 330-492-8001 and the on call physician will be paged.

Thank you for choosing Atrium!

The office is open. We are experiencing higher than normal call volumes due to cancellations. If you are wanting to reschedule or cancel, please consider leaving a message as opposed to holding or queing. Our team will work to return your call as soon as possible.

We will not be charging a fee for late cancellations today. Thank you for your patience and your trust!

Due to the inclement weather, the practice will delay our start time on Monday, 1/26/26 to 10:30a.

If you are scheduled for an appointment tomorrow prior to 10:30a, our team is working to notify you.

If you would like to cancel or reschedule your appointment for tomorrow, please call the office after 10:30a or you may email [email protected] for tomorrow's appointments only.

Thank you for choosing Atrium!

The office will close at Noon on Christmas Eve. We will reopen on Friday, 12/26 at 7:30a.

If you are in labor, please call the on call physician at 330-492-8001.

The office is closed this afternoon for our annual holiday party.

We will reopen on Monday, 12/8 at 7:30a.

If you are in labor, please call the on call physician at 330-492-8001.

Remember, it is still important to talk to your provider about your own unique health situation when deciding to start hormone therapy.

We agree with the FDA’s decision to remove the boxed warning on low-dose vaginal estrogen therapies used to treat genitourinary symptoms associated with menopause. The boxed warning may have been a deterrent to the use of the low-dose vaginal estrogen, which is a safe and effective therapy for a condition that affects most menopausal women. Systemic estrogen still comes with potential risks in certain individuals that should be reviewed in detail with women initiating therapy. As stated in The Menopause Society’s hormone therapy position statement, the risks are low for younger, healthy women initiating hormone therapy closer to the menopause transition. Risks are greater when initiated in older women and in those who are further from menopause onset. Medical comorbidities, personal and family histories, symptoms, and personal preferences all need to be reviewed with patients considering the use of hormone therapy for management of menopause symptoms or prevention of bone loss.

View The Menopause Society’s hormone therapy position statement at https://tinyurl.com/2h4zmav4.

Big news this week! Hormone therapy and menopause/perimenopause care are getting the attention they deserve after decades in the dark. Come visit our board-certified providers for individualized treatment options for your midlife symptoms.

HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy The U.S. Department of Health and Human Services (HHS) today announced historic action to restore gold-standard science to women’s health.

The office will be closed on Monday, October 20th, 2025.

If you think you are in labor or have a medical emergency, please report to the hospital or call 911.

We will return to the office on Tuesday, October 21st, 2025 at 7:30a.

Thank you!

UPDATE - Phones have been restored.

Hello -
Our phone lines are currently down. If you think you are in labor or have a medical emergency please report to the hospital or call 911.

We will update this page once the phones are working.

Thank you!